Exhibit 99.1

 

 

Stratasys Releases Second Quarter 2022 Financial Results

 

Second quarter revenue of $166.6 million, 13.3% growth over second quarter 2021 (16.4% on a constant currency basis), highest second quarter revenue in four years

 

Second quarter GAAP net loss of $24.4 million, or $0.37 per diluted share, and non-GAAP net income of $1.2 million, or $0.02 per diluted share

 

$441.5 million cash and equivalents and no debt as of June 30, 2022

 

Updates 2022 full-year outlook adjusted for currency exchange impact

 

MINNEAPOLIS & REHOVOT, Israel - (BUSINESS WIRE) - August 3, 2022 - Stratasys Ltd. (Nasdaq: SSYS), a leader in polymer 3D printing solutions, today announced financial results for the second quarter of 2022.

 

Summary - Second Quarter 2022 Financial Results Compared to Second Quarter 2021:

 

Revenue of $166.6 million, compared to $147.0 million.

 

GAAP gross margin of 40.5%, compared to 43.0%.

 

Non-GAAP gross margin of 47.6%, compared to 47.5%.

 

GAAP operating loss of $23.5 million, compared to a GAAP operating loss of $22.7 million.

 

Non-GAAP operating income of $1.9 million, compared to non-GAAP operating loss of $2.6 million.

 

GAAP net loss of $24.4 million, or ($0.37) per diluted share, compared to net loss of $20.2 million, or ($0.31) per diluted share.

 

Non-GAAP net income of $1.2 million, or $0.02 per diluted share, compared to non-GAAP net loss of $1.6 million, or ($0.02) per diluted share.

 

Adjusted EBITDA of $7.4 million, compared to $3.5 million.

 

$22.8 million of cash used by, compared to $5.6 million of cash generated from, operating activities, reflecting a continued augmentation of inventories.

 

“Our continued focus on execution delivered strong growth in revenue, margin, and earnings per share,” commented Dr. Yoav Zeif, Stratasys’ Chief Executive Officer. “Systems was again the main driver of robust performance, growing 29.2% from the prior year period and 9.7% over the same period in 2019. Our new Origin P3 and H350 SAF mass production manufacturing systems continue to ramp, with excellent customer engagement across all of our new technology offerings.”

 

Dr. Zeif continued, “We are advancing our leadership position by executing on our strategic initiatives and steadily expanding our reach into Fortune 500 manufacturing facilities worldwide. We continue to provide best-in-class, full-scale 3D printing solutions through our innovative and growing ecosystem of polymer additive manufacturing systems, expanding variety of materials, end-to-end software and top quality service. With our robust balance sheet and leading go-to-market strategy, we are well-positioned to navigate challenging supply issues and global inflation in our efforts to create long-term value for all of our shareholders.”

 

 

 

 

 

Financial Outlook:

 

Based on current market conditions and assuming that the impact of the COVID-19 pandemic, global supply chain costs, currency risk and inflation do not impede economic activity further, the Company is updating its outlook for 2022 as follows:

 

Full year revenue of $675 million to $685 million, as compared to a previous range of $685 million to $695 million. The reduction is primarily due to unexpected and adverse currency exchange rates which are expected to impact third and fourth quarter results relatively equally.

 

Revenue growth in the second half of the year approximately 6%-7% higher than the second half of 2021, with fourth quarter anticipated to grow at a higher rate than third quarter.

 

Based on current logistics and materials costs, third quarter gross margins relatively flat compared to third quarter of 2021, and full-year gross margins of flat to slightly higher than 2021.

 

Full year-operating expenses that are $18 million to $23 million higher than 2021, primarily due to ongoing investments in new products to drive higher revenue.

 

Full year non-GAAP operating margins slightly above 2%.

 

GAAP net loss of $78 million to $69 million, or ($1.17) to ($1.04) per diluted share.

 

Non-GAAP net income of $10 million to $13 million, or $0.14 to $0.19 per diluted share.

 

Adjusted EBITDA of $38 million to $41 million.

 

Capital expenditures of $20 million to $25.

 

Non-GAAP earnings guidance excludes $37 million to $38 million of projected amortization of intangible assets, $33 million to $35 million of share-based compensation expense, and reorganization and other expenses of $14 million to $16 million. Non-GAAP guidance includes tax adjustments of $2 million to $1 million on the above non-GAAP items.

 

Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

 

Stratasys Ltd. Second Quarter 2022 Webcast and Conference Call Details:

 

The Company plans to webcast its conference call to discuss its second quarter 2022 financial results on Wednesday, August 3, 2022, at 8:30 a.m. (ET).

 

The investor conference call will be available via live webcast on the Stratasys website at investors.stratasys.com, or directly at the following web address:

 

https://event.choruscall.com/mediaframe/webcast.html?webcastid=mUfZ38Qo

 

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

 

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

 

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

 

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

 

2

 

 

 

Cautionary Statement Regarding Forward-Looking Statements

 

The statements in this press release regarding Stratasys' strategy, and the statements regarding Stratasys’ projected future financial performance, including the financial guidance concerning its expected results for 2022 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the degree of our success at locating and acquiring additional value-enhancing, inorganic technology that furthers our business plan to lead in the realm of polymers; the potential adverse impact that recent global interruptions and delays involving freight carriers and other third parties (including due to the Russian invasion of Ukraine) may have on our supply chain and distribution network, and, consequently, our ability to successfully sell both our existing and newly-launched 3D printing products; the strength and duration of, and degree of recovery from and resilience to, the COVID-19 pandemic and/or adverse macro-economic trends that are, in part, by-products of that pandemic, such as inflation, which may have significant consequences for our operations, financial position, cash flows, and those of our customers and suppliers going forward; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2021, which we filed with the U.S. Securities and Exchange Commission, or SEC, on February 24, 2022 (the “2021 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2021 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2022, which will be furnished to the SEC throughout 2022, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Use of Non-GAAP Financial Measures

 

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

 

Yonah Lloyd 

CCO, VP Investor Relations 

Yonah.Lloyd@stratasys.com

 

Source: Stratasys Ltd.

 

3

 

 

Stratasys Ltd.

Consolidated Balance Sheets

(Unaudited)

(in thousands, except share data)

 

 

   June 30,   December 31, 
   2022   2021 
         
ASSETS          
           
Current assets          
Cash and cash equivalents  $255,886   $243,179 
Short-term deposits   182,429    259,000 
Accounts receivable, net of allowance for credit losses of $1.0 million and $0.5 million as of June 30, 2022 and December 31, 2021   132,343    129,382 
Inventories   153,702    129,147 
Prepaid expenses   8,225    6,871 
Other current assets   49,615    33,123 
           
Total current assets   782,200    800,702 
           
Non-current assets          
Property, plant and equipment, net   192,630    203,295 
Goodwill   64,959    65,144 
Other intangible assets, net   133,657    152,244 
Operating lease right-of-use assets   12,319    14,651 
Long-term investments   31,191    28,667 
Other non-current assets   12,886    12,519 
           
Total non-current assets   447,642    476,520 
           
Total assets  $1,229,842   $1,277,222 
           
LIABILITIES AND EQUITY          
           
Current liabilities          
Accounts payable  $61,316   $51,976 
Accrued expenses and other current liabilities   52,049    55,358 
Accrued compensation and related benefits   30,513    44,684 
Deferred revenues - short term   49,511    51,174 
Operating lease liabilities - short term   6,111    7,276 
           
Total current liabilities   199,500    210,468 
           
Non-current liabilities          
Deferred revenues - long term   22,727    21,133 
Deferred income taxes - long term   4,511    7,341 
Operating lease liabilities - long term   6,165    7,693 
Contingent consideration - long term   50,299    53,478 
Other non-current liabilities   22,931    21,095 
           
Total non-current liabilities   106,633    110,740 
           
Total liabilities   306,133    321,208 
           
Equity          
           
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 66,744 thousands shares and 65,677 thousands shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively   186    182 
Additional paid-in capital   3,030,088    3,012,481 
Accumulated other comprehensive loss   (13,354)   (8,771)
Accumulated deficit   (2,093,211)   (2,047,878)
    923,709    956,014 
           
Total liabilities and equity  $1,229,842   $1,277,222 

 

4

 

 

Stratasys Ltd.

Consolidated Statements of Operations

(in thousands, except per share data)

 

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2022   2021   2022   2021 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
Net sales                    
Products  $115,721   $100,305   $228,794   $190,629 
Services   50,882    46,700    101,238    90,565 
    166,603    147,005    330,032    281,194 
                     
Cost of sales                    
Products   61,132    49,731    120,505    96,651 
Services   38,078    34,004    72,457    65,696 
    99,210    83,735    192,962    162,347 
                     
Gross profit   67,393    63,270    137,070    118,847 
                     
Operating expenses                    
Research and development, net   24,346    22,437    48,344    43,038 
Selling, general and administrative   66,592    63,557    131,855    116,891 
    90,938    85,994    180,199    159,929 
                     
Operating loss   (23,545)   (22,724)   (43,129)   (41,082)
                     
Financial expenses, net   (1,170)   (372)   (2,532)   (749)
                     
Loss before income taxes   (24,715)   (23,096)   (45,661)   (41,831)
                     
Income tax benefit   429    4,368    502    5,310 
                     
Share in losses of associated companies   (99)   (1,431)   (174)   (2,549)
                     
Net loss  $(24,385)  $(20,159)  $(45,333)  $(39,070)
                     
Net loss per share                    
Basic  $(0.37)  $(0.31)  $(0.69)  $(0.63)
Diluted  $(0.37)  $(0.31)  $(0.69)  $(0.63)
                     
Weighted average ordinary shares outstanding                    
Basic   66,568    64,908    66,151    61,796 
Diluted   66,568    64,908    66,151    61,796 

 

5

 

 

      Three Months Ended June 30, 
      2022   Non-GAAP   2022   2021   Non-GAAP   2021 
      GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP 
      U.S. dollars and shares in thousands (except per share amounts) 
  Gross profit (1)  $67,393   $11,914   $79,307   $63,270   $6,616   $69,886 
   Operating income (loss)  (1,2)   (23,545)   25,479   $1,934    (22,724)   20,133   $(2,591)
   Net income (loss) (1,2,3)   (24,385)   25,560   $1,175    (20,159)   18,581   $(1,578)
   Net income (loss) per diluted share (4)  $(0.37)  $0.39   $0.02   $(0.31)  $0.29   $(0.02)
                                  
(1)  Acquired intangible assets amortization expense        6,954              5,518      
   Non-cash stock-based compensation expense        1,080              788      
   Restructuring and other related costs        15              310      
   Impairment charges        3,865              -      
            11,914              6,616      
                                  
(2)  Acquired intangible assets amortization expense        2,218              2,200      
   Non-cash stock-based compensation expense        7,751              7,189      
   Restructuring and other related costs        -              350      
   Revaluation of investments        1,255              2,201      
   Contingent consideration        596              202      
   Other expenses        1,745              1,375      
            13,565              13,517      
            25,479              20,133      
                                  
(3)  Corresponding tax effect and other expenses        81              (1,552)     
           $25,560             $18,581      
                                  
(4)  Weighted average number of ordinary shares outstanding - Diluted   66,568         67,070    64,908         64,908 

 

6

 

  

      Six Months Ended June 30, 
      2022   Non-GAAP   2022   2021   Non-GAAP   2021 
      GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP 
      U.S. dollars and shares in thousands (except per share amounts) 
  Gross profit (1)  $137,070   $19,603   $156,673   $118,847   $13,685   $132,532 
   Operating income (loss)  (1,2)   (43,129)   47,086   $3,957    (41,082)   35,918   $(5,164)
   Net income (loss) (1,2,3)   (45,333)   47,718   $2,385    (39,070)   33,692   $(5,378)
   Net income (loss) per diluted share (4)  $(0.69)  $0.73   $0.04   $(0.63)  $0.54   $(0.09)
                                  
(1) Acquired intangible assets amortization expense        13,920              10,873      
   Non-cash stock-based compensation expense        1,980              1,422      
   Restructuring and other related costs        (162)             1,390      
   Impairment charges        3,865              -      
            19,603              13,685      
                                  
(2) Acquired intangible assets amortization expense        4,443              4,393      
   Non-cash stock-based compensation expense        15,384              13,760      
   Restructuring and other related costs        555              2,159      
   Revaluation of investments        2,316              (1,469)     
   Contingent consideration        803              393      
   Other expenses        3,982              2,997      
            27,483              22,233      
            47,086              35,918      
                                  
(3) Corresponding tax effect and other expenses        632              (2,226)     
           $47,718             $33,692      
                                  
(4) Weighted average number of ordinary shares outstanding - Diluted   66,151         67,071    61,796         61,796 

 

7

 

 

Stratasys Ltd.

Reconciliation of GAAP to Non-GAAP Forward Looking Guidance

Fiscal Year 2022

(in millions, except per share data)

 

 

GAAP net loss  ($78) to ($69)
    
Adjustments   
Stock-based compensation expense  $33 to $35
Intangible assets amortization expense  $37 to $38
Reorganization and other  $14 to $16
Tax expense (benefit) related to Non-GAAP adjustments  ($2) to ($1)
    
Non-GAAP net income  $10 to $13
    
GAAP loss per share  ($1.17) to ($1.04)
    
Non-GAAP diluted earnings per share  $0.14 to $0.19

 

 

8